Ignite Creation Date:
2024-10-26 @ 3:41 PM
Last Modification Date:
2024-10-26 @ 3:41 PM
Study NCT ID:
NCT06611787
Status:
RECRUITING
Last Update Posted:
None
First Post:
2024-08-15
Brief Title:
A Comprehensive Registry Study of the Whole Life Cycle of Patients With CHD
Sponsor:
None
Organization:
None
Study Overview
Official Title:
A Comprehensive Registry Study of the Whole Life Cycle of Patients With Congenital Heart Diseases
Status:
RECRUITING
Status Verified Date:
2024-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This observational study aims to collect data on the prevalence intervention and prognosis of congenital heart disease CHD in Chinese patients across their entire lifecycle From the diagnosis of CHD in fetuses to early treatment of severe CHD in neonates to standardized perinatal diagnosis and treatment of CHD patients with concurrent pregnancy the study employs a cyclical model consisting of evaluation training improvement and re-evaluation The goal is to enhance the diagnostic and treatment capabilities of participating hospitals especially for complex CHD cases and promote standardized clinical practices in cardiovascular disease treatment among these hospitals This will ultimately improve the quality of medical services provided to cardiovascular patients and serve as a basis for exploring CHD treatment guidelines suitable for China
The project will be implemented by Capital Medical University Affiliated Beijing Anzhen Hospital and the National Clinical Research Center for Cardiovascular Diseases The plan is to involve more than 20 hospitals over the next five years An independent website will be created for data collection education and training as well as experience sharing among participating hospitals Starting from January 1 2024 each hospital will continuously collect CHD inpatient cases on a monthly basis The project team will regularly analyze and report on the completion of key medical quality evaluation indicators for each hospital They will provide guidance measures such as education training experience sharing and on-site investigations to address identified issues helping hospitals improve medical quality Hospitals that demonstrate excellence and significant improvement will be recognized and commended driving overall improvement in the quality of cardiovascular medical care in China
The project will be implemented by Capital Medical University Affiliated Beijing Anzhen Hospital and the National Clinical Research Center for Cardiovascular Diseases The plan is to involve more than 20 hospitals over the next five years An independent website will be created for data collection education and training as well as experience sharing among participating hospitals Starting from January 1 2024 each hospital will continuously collect CHD inpatient cases on a monthly basis The project team will regularly analyze and report on the completion of key medical quality evaluation indicators for each hospital They will provide guidance measures such as education training experience sharing and on-site investigations to address identified issues helping hospitals improve medical quality Hospitals that demonstrate excellence and significant improvement will be recognized and commended driving overall improvement in the quality of cardiovascular medical care in China
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None